Dr. Roghmann is an infectious disease physician and clinical investigator. She received her M.D. from the Johns Hopkins University School of Medicine and her M.S. from the Department of Epidemiology and Public Health at the University of Maryland. Dr. Roghmann is an Professor in the Department of Epidemiology and Public Health. She directs the Clinical Research Curriculum Program, which is funded through a NIH K30 award. She is also the Hospital Epidemiologist for the VA Maryland Health Care System.
Dr. Roghmann’s research interests are focused on understanding bacterial and host determinants of S. aureus colonization, transmission and infection with the goal of developing better ways of preventing healthcare-associated S. aureus infections including those caused by MRSA She has had research funding from the National Institutes of Health (NIH), Veterans Health Administration Research and Development (VA), Agency for Health Care Research and Quality (AHRQ) and the Centers for Disease Control and Prevention (CDC).
- Molecular epidemiology of S. aureus
- Metagenomics, S. aureus colonization and Healthcare Associated Infections
- Prevention of MRSA Transmission in Long Term Care Settings
- Risk factors for Severe Infections in People with S. aureus infections
Adult infectious diseases
Grants and Contracts:
- National Institutes of Health, National Institute for Allergy and Infectious Diseases: Metagenomics and Health Care Associated Infections, Principal Investigator, 2011- 2015
- Agency for Healthcare Research and Quality (AHRQ) Modifying Contact Precautions for MRSA in Extended Care, Principal Investigator, 2011- 2014
- VA Health Services Research & Development: Modifying Contact Precautions in Non-Acute Care Settings, Principal Investigator, 2012- 2016
- VA Clinical Science Research & Development: Metagenomic Studies of MRSA Colonization, Principal Investigator, 2012- 2016
Furuno JP, Shurland SM, Zhan M, Johnson JK, Venezia RA, Harris AD, Roghmann MC. Comparison of the Methicillin-Resistant Staphylococcus aureus Acquisition among Rehabilitation and Nursing Home Residents. Infect Control Hosp Epidemiol. 2011;32(3):244-249.
Roghmann MC, Johnson JK, Stine OC, Lydecker AD, Ryan KA, Mitchell BD, Shuldiner AR. Persistent Staphylococcus aureus Colonization is Not a Strongly Heritable Trait in Amish Families. PLoS One. 2011;6(2):e17368.
Tracy LA, Furuno JP, Harris AD, Singer M, Langenberg P, Roghmann MC. Staphylococcus aureus Infections in US Veterans, Maryland, USA, 1999-2008. Emerg Infect Dis. 2011;17(3):441-448.
Ajao AO, Harris AD, Roghmann MC, Johnson JK, Zhan M, McGregor JC, Furuno JP. Systematic Review of Measurement and Adjustment for Colonization Pressure in Studies of Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococci, and Clostridium difficile Acquisition. Infect Control Hosp Epidemiol. 2011;32(5):481-489.
Kreisel KM, Stine OC, Johnson JK, Perencevich EN, Shardell MD, Lesse AJ, Gordin FM, Climo MW, Roghmann MC. USA300 Methicillin-Resistant Staphylococcus Aureus Bacteremia and the Risk of Severe Sepsis: Is USA300 Methicillin-Resistant Staphylococcus aureus Associated with More Severe Infections? Diagn Microbiol Infect Dis. 2011;70(3):285-290.
Shurland SM, Stine OC, Venezia RA, Zhan M, Furuno JP, Miller RR, Roghmann MC. USA300 Methicillin-Resistant Staphylococcus aureus (USA300 MRSA) Colonization and the Risk of MRSA Infection in Residents of Extended-Care Facilities. Epidemiol Infect. 2012;140(3):390-399.
Adhikari RP, Ajao AO, Aman MJ, Karauzum H, Sarwar J, Lydecker AD, Johnson JK, Nguyen C, Chen WH, Roghmann MC. Lower Antibody Levels to Staphylococcus aureus Exotoxins are associated with Sepsis in Hospitalized Adults with Invasive Staphylococcus aureus Infections. Journal of Infectious Diseases 2012; doi: 10.1093/infdis/jis462
Links of Interest:Division of Genomic Epidemiology & Clinical Outcomes
Faculty members: Update your contact information and create a profile.